Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026)
Rigel Pharmaceuticals (RIGL) recorded quarterly Current Leases of $636000.0 in Q1 2026, up 3.58% quarter-over-quarter from $614000.0 in Q4 2025, and up 39.47% on a YoY basis from $456000.0 in Q1 2025.
Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Current Leases history runs 15 years deep, the most recent figure standing at $636000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 39.47% year-over-year to $636000.0; the TTM figure through Mar 2026 stood at $636000.0 (up 39.47% YoY), while the FY2025 annual figure was $614000.0, up 115.44% from the prior year.
- Current Leases was $636000.0 for Q1 2026 at Rigel Pharmaceuticals, up from $614000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $8.3 million in Q1 2022 to a low of $285000.0 in Q4 2024.
- Historically, Current Leases has averaged $1.5 million across 5 years, with a median of $636000.0 in 2026.
- The sharpest annual moves came in 2023 and 2025: Current Leases plunged 94.59% in 2023, then soared 115.44% in 2025.
- A 5-year view of Current Leases shows it stood at $1.1 million in 2022, then sank by 38.92% to $692000.0 in 2023, then tumbled by 58.82% to $285000.0 in 2024, then jumped by 115.44% to $614000.0 in 2025, then gained by 3.58% to $636000.0 in 2026.
- The last three Current Leases figures came in at $636000.0 (Q1 2026), $614000.0 (Q4 2025), and $594000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | 636,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 614,000.00 |
| Sep 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 517,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 466,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Dec 31, 2023 | 692,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 449,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 5.81 Mn |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 9.89 Mn |
| Sep 30, 2021 | 9.57 Mn |
| Jun 30, 2021 | 9.22 Mn |